Clinical Trial Update: 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial using PET imaging to evaluate response to cetuximab plus cisplatin and radiation in advanced cancers of the oropharynx, larynx, or hypopharynx…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oropharyngeal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Platinol (cisplatin)

Snippet

Sponsor: Mayo Clinic | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: COMPLETED